Fixed-Combination Therapy for Moderate to Severe Acne: A Review of Clindamycin Phosphate 1.2%-Benzoyl Peroxide 2.5% Gel

Article Type
Changed
Thu, 01/10/2019 - 13:05
Display Headline
Fixed-Combination Therapy for Moderate to Severe Acne: A Review of Clindamycin Phosphate 1.2%-Benzoyl Peroxide 2.5% Gel

Article PDF
Author and Disclosure Information

Cook-Bolden FE

Issue
Cutis - 89(2)
Publications
Topics
Page Number
87-92
Legacy Keywords
acne, combination therapy, benzoyl peroxide, clindamycin phosphate, BPO, Cook-Bolden FE
Sections
Author and Disclosure Information

Cook-Bolden FE

Author and Disclosure Information

Cook-Bolden FE

Article PDF
Article PDF

Issue
Cutis - 89(2)
Issue
Cutis - 89(2)
Page Number
87-92
Page Number
87-92
Publications
Publications
Topics
Article Type
Display Headline
Fixed-Combination Therapy for Moderate to Severe Acne: A Review of Clindamycin Phosphate 1.2%-Benzoyl Peroxide 2.5% Gel
Display Headline
Fixed-Combination Therapy for Moderate to Severe Acne: A Review of Clindamycin Phosphate 1.2%-Benzoyl Peroxide 2.5% Gel
Legacy Keywords
acne, combination therapy, benzoyl peroxide, clindamycin phosphate, BPO, Cook-Bolden FE
Legacy Keywords
acne, combination therapy, benzoyl peroxide, clindamycin phosphate, BPO, Cook-Bolden FE
Sections
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media

Addressing Disorders of Hyperpigmentation With Combination Therapy: A Marriage of Mother Nature, Medicine, and Modalities [editorial]

Article Type
Changed
Thu, 01/10/2019 - 13:04
Display Headline
Addressing Disorders of Hyperpigmentation With Combination Therapy: A Marriage of Mother Nature, Medicine, and Modalities [editorial]

Article PDF
Author and Disclosure Information

Cook-Bolden FE

Issue
Cutis - 88(5)
Publications
Topics
Page Number
501-503
Legacy Keywords
hyperpigmentation, hydroquinone, dyschromia, postinflammatory hyperpigmentation, Fran E. Cook-Boldenhyperpigmentation, hydroquinone, dyschromia, postinflammatory hyperpigmentation, Fran E. Cook-Bolden
Sections
Author and Disclosure Information

Cook-Bolden FE

Author and Disclosure Information

Cook-Bolden FE

Article PDF
Article PDF

Issue
Cutis - 88(5)
Issue
Cutis - 88(5)
Page Number
501-503
Page Number
501-503
Publications
Publications
Topics
Article Type
Display Headline
Addressing Disorders of Hyperpigmentation With Combination Therapy: A Marriage of Mother Nature, Medicine, and Modalities [editorial]
Display Headline
Addressing Disorders of Hyperpigmentation With Combination Therapy: A Marriage of Mother Nature, Medicine, and Modalities [editorial]
Legacy Keywords
hyperpigmentation, hydroquinone, dyschromia, postinflammatory hyperpigmentation, Fran E. Cook-Boldenhyperpigmentation, hydroquinone, dyschromia, postinflammatory hyperpigmentation, Fran E. Cook-Bolden
Legacy Keywords
hyperpigmentation, hydroquinone, dyschromia, postinflammatory hyperpigmentation, Fran E. Cook-Boldenhyperpigmentation, hydroquinone, dyschromia, postinflammatory hyperpigmentation, Fran E. Cook-Bolden
Sections
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media

An Open-Label Study of the Efficacy and Tolerability of Microencapsulated Hydroquinone 4% and Retinol 0.15% With Antioxidants for the Treatment of Hyperpigmentation

Article Type
Changed
Thu, 01/10/2019 - 12:14
Display Headline
An Open-Label Study of the Efficacy and Tolerability of Microencapsulated Hydroquinone 4% and Retinol 0.15% With Antioxidants for the Treatment of Hyperpigmentation

Article PDF
Author and Disclosure Information

Cook-Bolden FE, Hamilton SF

Issue
Cutis - 81(4)
Publications
Topics
Page Number
365-371
Sections
Author and Disclosure Information

Cook-Bolden FE, Hamilton SF

Author and Disclosure Information

Cook-Bolden FE, Hamilton SF

Article PDF
Article PDF

Issue
Cutis - 81(4)
Issue
Cutis - 81(4)
Page Number
365-371
Page Number
365-371
Publications
Publications
Topics
Article Type
Display Headline
An Open-Label Study of the Efficacy and Tolerability of Microencapsulated Hydroquinone 4% and Retinol 0.15% With Antioxidants for the Treatment of Hyperpigmentation
Display Headline
An Open-Label Study of the Efficacy and Tolerability of Microencapsulated Hydroquinone 4% and Retinol 0.15% With Antioxidants for the Treatment of Hyperpigmentation
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media